National Gross Margin from 2010 to 2024

NHI Stock  USD 61.52  1.08  1.79%   
Check National Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among National main balance sheet or income statement drivers, such as Depreciation And Amortization of 73.5 M, Interest Expense of 58.3 M or Total Revenue of 170.8 M, as well as many exotic indicators such as Price To Sales Ratio of 7.26, Dividend Yield of 0.0868 or PTB Ratio of 1.84. National financial statements analysis is a perfect complement when working with National Health Valuation or Volatility modules.
  
This module can also supplement National Health's financial leverage analysis and stock options assessment as well as various National Health Technical models . Check out the analysis of National Health Correlation against competitors.

About National Health Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include National Health income statement, its balance sheet, and the statement of cash flows. National Health investors use historical funamental indicators, such as National Health's Gross Margin, to determine how well the company is positioned to perform in the future. Although National Health investors may use each financial statement separately, they are all related. The changes in National Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on National Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on National Health Financial Statements. Understanding these patterns can help to make the right decision on long term investment in National Health. Please read more on our technical analysis and fundamental analysis pages.
is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHIs portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. National Health operates under REITHealthcare Facilities classification in the United States and is traded on New York Stock Exchange. It employs 19 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:
Check out the analysis of National Health Correlation against competitors.
Note that the National Health Investors information on this page should be used as a complementary analysis to other National Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Complementary Tools for National Stock analysis

When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Is National Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.14)
Dividend Share
3.6
Earnings Share
3.13
Revenue Per Share
7.384
Quarterly Revenue Growth
(0.12)
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.